Valneva SEWBO:VLA +1.32%56 Median PS Value is €2.25 as of Jun. 28, 2026, which is 100% below its 10-year median of 0.93. GuruFocus rates WBO:VLA with a GF Score™ of 56/100 and a GF Value™ of €2.46 (Fairly Valued). The stock has 6 warning signs investors should review. Among 277 Biotechnology companies, Valneva SE ranks worse than 73.29% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Valneva SE's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.903. Valneva SE's 10-Year median PS Ratio is 2.4917. Therefore, the Median PS Value for today is €2.25.
As of today (2026-06-28), Valneva SE's share price is €2.229. Valneva SE's Median PS Value is €2.25. Therefore, Valneva SE's Price to Median PS Value for today is 0.99.
The historical rank and industry rank for Valneva SE's Median PS Value or its related term are showing as below:
WBO:VLA'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.3 Med: 0.93 Max: 1.83
Current: 0.99
During the past 13 years, the highest Price to Median PS Value of Valneva SE was 1.83. The lowest was 0.30. And the median was 0.93.
WBO:VLA's Price-to-Median-PS-Value is ranked worse than 73.29% of 277
companies
in the Biotechnology industry
Industry Median: 0.62
vs WBO:VLA: 0.99
Valneva SE (WBO:VLA) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Valneva SE's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
2.229
/
2.25
=
0.99
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Valneva SE Median PS Value Related Terms
Valneva SE Median PS Value Historical Data
* Premium members only.
The historical data trend for Valneva SE's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:VLA vs VRTX, REGN, ALNY: Median PS Value Comparison
For the Biotechnology subindustry, Valneva SE's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Valneva SE Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Valneva SE's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Valneva SE's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 2.4917.
Valneva SE's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.903.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Valneva SE (WBO:VLA) has a Median PS Value of €2.25 as of Jun. 28, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Valneva SE and its competitors. This is 142% above median its historical median of 0.93. Over the past decade, Valneva SE's Median PS Value has ranged from 0.30 to 1.83. According to the industry distribution chart, Valneva SE ranks #203 out of 277 companies in the Biotechnology industry, placing it in the top 73.3%.
Is Valneva SE's Median PS Value too high?
Valneva SE's current Median PS Value of €2.25 is 142% above median its 10-year median of 0.93. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 1.83. Based on the distribution chart, Valneva SE ranks #203 out of 277 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Valneva SE has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Valneva SE's Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Valneva SE ranks #203 out of 277 companies for Median PS Value. This places Valneva SE in the lower half of its industry. The industry median Median PS Value is 0.62. Historically, Valneva SE's own Median PS Value has ranged from 0.30 to 1.83 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.62, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Valneva SE and its competitors. For the Biotechnology industry, the median Median PS Value is 0.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Valneva SE's current Median PS Value is €2.25, which is 142% above median its own 10-year median of 0.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valneva SE stock overvalued right now?
Based on GuruFocus' analysis, Valneva SE (WBO:VLA) is currently considered Fairly Valued. The stock's GF Value™ is €2.46, compared to a current price of €2.23 — trading 9.4% below its estimated fair value. The current Median PS Value is €2.25, which is 142% above median its 10-year median of 0.93. Valneva SE's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Valneva SE (WBO:VLA), the current Median PS Value is €2.25 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Valneva SE (WBO:VLA) Overvalued in 2026?
Based on GuruFocus' analysis, Valneva SE stock appears to be undervalued.
The current stock price of €2.23 is trading 9.4% below its estimated GF Value™ of €2.46.
GuruFocus considers Valneva SE to be Fairly Valued.
Key valuation signals for WBO:VLA:
Median PS Value: €2.25 (142% above median its 10-year median of 0.93)
GF Value™: €2.46 vs. price of €2.23 (9.4% below fair value)
No single metric tells the full story. See the WBO:VLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
56GF Score
Get the complete analysis for WBO:VLA
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:VLA has been successfully added to your 
